Indicia Biotechnology - Immuno-Monitoring Activities' Unit Acquisition

Indicia Biotechnology - Immuno-Monitoring Activities raised a round of funding on June 26, 2013. Investors include Platine Pharma Services.

Indicia is a global provider of outsourced development and bioanalytical services to the pharmaceutical, biotechnology and medical device industries. The company's immuno-monitoring activities are the…

Articles about Indicia Biotechnology - Immuno-Monitoring Activities' Unit Acquisition: